Related Experiment Video
Updated: Apr 17, 2026

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
Research status of Budd-Chiari syndrome in China
Xiaowei Dang1, Luhao Li1, Peiqin Xu1
1Department of Hepatopancreatobiliary Surgery, First Affiliated Hospital of Zhengzhou University Zhengzhou 450052, China.
Insights
Budd-Chiari syndrome (B-CS) is a rare liver condition with distinct characteristics in China compared to Western countries. Further research into its complex pathogenesis is crucial for effective treatment and improved patient quality of life.
Area of Science:
- Hepatology
- Internal Medicine
- Gastroenterology
Background:
- Budd-Chiari syndrome (B-CS) is a rare hepatic vascular disorder characterized by obstruction of hepatic venous outflow.
- Significant geographical variations exist in B-CS subtypes and clinical presentations.
- The pathogenesis of B-CS in China differs notably from Western countries, involving complex multifactorial processes.
Purpose of the Study:
- To investigate the complex and multifactorial pathogenesis of Budd-Chiari syndrome.
- To understand the specific etiological factors contributing to B-CS in the Chinese population.
- To highlight the importance of understanding B-CS pathogenesis for improved patient outcomes.
Main Methods:
- This study focuses on analyzing the pathogenesis of Budd-Chiari syndrome.
- Comparative analysis of B-CS characteristics between China and Western countries.
- Review of existing literature and clinical data on B-CS etiology.
Main Results:
- Budd-Chiari syndrome exhibits significant geographical differences in its subtypes and clinical features.
- The underlying causes and pathological mechanisms of B-CS in China are distinct from those observed in Western populations.
- The etiology of B-CS is complex and influenced by multiple factors, with specific causes remaining unclear.
Conclusions:
- Understanding the unique pathogenesis of Budd-Chiari syndrome in different regions is critical.
- Further in-depth research into B-CS pathogenesis is essential for developing targeted prevention and treatment strategies.
- Elucidating the disease mechanisms will significantly improve the quality of life for patients suffering from Budd-Chiari syndrome.
Abstract:
Budd-Chiari syndrome (B-CS) is a disease with a low incidence and has obvious geographical difference in subtype and clinical characteristics. The pathogenesis of B-CS in China is significantly different from that in western countries and is a complex process involving multiple factors. However, the specific cause of this disease is not yet clear. In-depth understanding of B-CS pathogenesis will be of great importance in preventing and treating the disease and improving the quality of life of the patients.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Portal Hypertension

